Your choices go into the PDF (cover and captions); this bar does not.
Rebalix
Comparison report · official data side by side

IE00B3Z3FS74 vs LU0950674175


IE00B3Z3FS74UBS MSCI EM SF UCITS ETF USD acc
IE00B3Z3FS74 · Equity · Emerging markets
LU0950674175UBS Core MSCI EM UCITS ETF USD acc
LU0950674175 · Equity · Emerging markets
Open the interactive comparison on rebalix.com →

Comparison window: 18 Jun 20188 Sept 2026 (max: from the most recent launch) · currency: 🇪🇺 EUR · inflation: 🇮🇹 Italy · distributions: reinvested where declared

Report produced on 10 September 2026 · data as of the dates shown per section
Sources: official issuer documents (KID, factsheet, declared NAV series and holdings), ESMA register, ECB rates, Eurostat
Public methodology: rebalix.com/en/methodology

Informational document generated by rebalix.com — facts side by side, no recommendations. It does not constitute investment advice or investment research under Directive 2014/65/EU (MiFID II). Past performance is not indicative of future results.

RebalixIE00B3Z3FS74 vs LU0950674175 · report of 10 September 2026

The funds at a glance

From official issuer documents and the ESMA register
IE00B3Z3FS74IE00B3Z3FS74UBS MSCI EM SF UCITS ETF USD accEquity · Emerging markets
Declared index
MSCI Emerging Markets Total Return Net
TER
0.14%
Transaction (KID)
0.00%
Fund size
141 mln EUR
Launch
27 Apr 2011
Currency
USD
Replication
Synthetic (swap)
Hedging
No
Holdings
0
Effective 🇮🇹 rate
LU0950674175LU0950674175UBS Core MSCI EM UCITS ETF USD accEquity · Emerging markets
Declared index
MSCI Emerging Markets Total Return Net
TER
0.15%
Transaction (KID)
0.01%
Fund size
7.5 mld EUR
Launch
18 Jun 2018
Currency
USD
Replication
Physical (mixed: optimised/sampled)
Hedging
No
Holdings
0
Effective 🇮🇹 rate
26.00%

Tracking difference — year by year

Fund minus index, from issuer-declared series (complete calendar years). Each measures adherence to its OWN index.
IE00B3Z3FS743y avg: −0.04%/anno
2025
−0.12%
2024
−0.02%
2023
+0.02%
2022
+0.00%
2021
−0.15%
2020
−0.47%
LU09506741753y avg: +0.08%/anno
2025
+0.29%
2024
+0.21%
2023
−0.26%
2022
+0.15%
2021
−0.58%
2020
−0.20%
Rebalix · IE00B3Z3FS74 vs LU0950674175section 1 of 3
RebalixIE00B3Z3FS74 vs LU0950674175 · report of 10 September 2026
IE00B3Z3FS74UBS MSCI EM SF UCITS ETF USD acc · IE00B3Z3FS74 · Equity · Emerging markets
LU0950674175UBS Core MSCI EM UCITS ETF USD acc · LU0950674175 · Equity · Emerging markets

Performance over the period, in euro

From 18 Jun 2018 to 8 Sept 2026 · base 100 · ECB rates, dividends reinvested where declared
In euro (nominal)
10019976191192
In today’s purchasing power (net of Italy inflation)
10019976155156
IE00B3Z3FS74LU0950674175
Same scale in both panels: the gap between endpoints is Italian inflation over the period (Eurostat). Volatility stays nominal, as everywhere on the site.

How far they fell — drawdown from peak (nominal)

In euro · distance from the previous peak, day by day, on NAV: for distributing classes it includes ex-dividend drops (slightly deeper than total return)
0%-10%-20%-30%-40%-50%IE00B3Z3FS74LU095067417520192020202120222023202420252026trough IE00B3Z3FS74: −31.9% · 23 Mar 2020trough LU0950674175: −31.9% · 23 Mar 2020
Filled area: IE00B3Z3FS74; thin lines: the other funds.
The worst episode, fund by fund
FundMax drawdownTroughRecovery timeUnderwater
IE00B3Z3FS74−31.9%23 Mar 2020242 days305 days · back to break-even on 20 Nov 2020
LU0950674175−31.9%23 Mar 2020238 days301 days · back to break-even on 16 Nov 2020
"Recovery time" = the climb only: trough to break-even (0%). "Underwater" = decline + recovery: peak to break-even.

Drawdown net of Italy inflation

Same curve in purchasing-power terms: as on the site, drawdown follows the real view (volatility stays nominal, per methodology)
0%-10%-20%-30%-40%-50%IE00B3Z3FS74LU095067417520192020202120222023202420252026trough IE00B3Z3FS74: −36.8% · 28 Oct 2022trough LU0950674175: −37.1% · 28 Oct 2022
In real terms declines are deeper and recoveries slower. Monthly price index (Eurostat), held at the last published value.
Rebalix · IE00B3Z3FS74 vs LU0950674175section 2 of 3
RebalixIE00B3Z3FS74 vs LU0950674175 · report of 10 September 2026

Full comparison table

"—" = not published by the source, never estimated
IE00B3Z3FS74UBS MSCI EM SF UCITS ETF USD acc · IE00B3Z3FS74 · Equity · Emerging markets
LU0950674175UBS Core MSCI EM UCITS ETF USD acc · LU0950674175 · Equity · Emerging markets
MetricIE00B3Z3FS74LU0950674175Note
Identity
CategoryEquity · Emerging marketsEquity · Emerging marketsRebalix engine classification
ReplicationSynthetic (swap)Physical (mixed: optimised/sampled)as declared by the issuer
Currency hedgingNoNosource: class name, factsheet
Income policyaccumulatingaccumulating
Costs
TER0.14%0.15%from the KID
Transaction costs (KID)0.00%0.01%internal
All-in cost0.14%0.16%TER + transaction
Tracking difference (3a)−0.04%+0.08%vs its OWN index
Performance in euro (ECB rates)
1 year+40.9%+41.0%
3 years+76.8%+77.6%
5 years+52.0%+52.8%
10 years+125.6%— = series younger than the window
Risk · last 3 years
Volatility (ann.)+17.85%+17.90%
Max drawdown−15.79%−15.56%
Sharpe1.111.13risk-free = ECB MRO avg
Sortino1.601.63like Sharpe, downside only
Italian taxation
Effective capital-gains rate26.00%white list, current half-year
Documents & exchanges
Listing venues52ESMA register
Borsa Italiana tickerEMGEASEMMUSC
Indicative cumulative cost: on 10,000 euro over 5 years (stated assumption: 5%/yr growth, cost = TER + transaction) ~89 euro IE00B3Z3FS74 · ~102 euro LU0950674175. Broker costs not included.

Disclaimer

This document is for information only and does not constitute investment advice under Directive 2014/65/EU (MiFID II), investment research, a personal recommendation, or an offer or solicitation to buy or sell financial instruments.

Past performance is not indicative of, nor a guarantee of, future results. The value of an investment can go down as well as up and investors may not get back the capital invested. Euro returns are affected by currency fluctuations.

Before any investment decision, read the KID and the Prospectus, available from the issuers. Tax treatment depends on individual circumstances and may change.

Data come from official issuer documents and public registers, following the public methodology at rebalix.com/en/methodology. "—" fields were not published by the source and have not been estimated. Rebalix receives no compensation from the issuers mentioned.

Rebalix · IE00B3Z3FS74 vs LU0950674175section 3 of 3